Health

This is to provide Latest HealthNews around the globe

  • Uncertainty clouds future of tibb colleges and hakeems in Pakistan – Pakistan

    Hakeems believe they are the only practitioners consistently working in far-flung regions, noting that MBBS doctors, even those from rural backgrounds, rarely practise in their native areas. When Arsalan Ali walks into his classroom, he is no longer sure whether the degree he is working towards will exist by the time he graduates. He’s a trained pharmaceutical chemist with an…

    Read More »
  • Intermittent calorie restriction proves as effective as daily calorie cuts for type 2 diabetes

    In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: New clinical research suggests both continuous and intermittent calorie restriction improve metabolic health in type 2 diabetes, with adherence emerging as a key factor in real-world success. Study: The effect of continuous or intermittent calorie-restricted diet…

    Read More »
  • USANA Health Sciences Q4 Earnings Call Highlights

    USANA Health Sciences logo Leadership reset: Kevin Guest has returned as CEO while remaining chairman and set six priorities to refocus USANA as a modern, science-driven nutrition company, emphasizing omnichannel growth, product innovation, tech modernization and a shift to in-house manufacturing. Fiscal 2026 outlook: Management expects consolidated net sales to grow roughly about 4% at the midpoint, with growth driven…

    Read More »
  • How GLP-1 drugs affect the body beyond weight loss and glucose control

    In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. A recent review article published in the Journal of Clinical Investigation…

    Read More »
  • Week 5 of the 2026 Session

    House Committee on Child Welfare and Foster Care(Rep. Cyndi Howerton, Chair) On Monday, Feb. 9, the Committee held a hearing on HB 2639, which would rename juvenile crisis intervention centers as juvenile stabilization centers, modify admission criteria and services provided at such centers, revise related statutory language in the Child in Need of Care (CINC) and Juvenile Offender Codes, and…

    Read More »
  • Health Catalyst Appoints Ben Albert as Chief Executive Officer

    Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in Healthcare Health Catalyst Board to be Reduced to Five Directors Immediately Prior to the 2026 Annual Meeting SALT LAKE CITY, Feb. 18, 2026 /PRNewswire/ — Health Catalyst, Inc. (Nasdaq: HCAT) (“Health Catalyst” or the “Company”), a leading provider of data and analytics technology and services…

    Read More »
  • Wyoming wants to make its five-year federal rural health funding last ‘forever’

    In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: Wyoming officials say they have a plan to make five years of upcoming grants from a new $50 billion federal rural health program last “forever.” The state could tackle rural health issues long into the future…

    Read More »
  • Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

    In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: Emerging evidence suggests widely used metabolic drugs could influence brain aging pathways, yet large clinical trials are still needed to confirm whether they truly alter the course of neurodegenerative disease. Study: The promise of GLP-1 receptor…

    Read More »
  • FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma’s Biosimilar to NEUPOGEN® (filgrastim)

    In the news release, FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma’s Biosimilar to NEUPOGEN® (filgrastim), issued 17-Feb-2026 by Accord BioPharma over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end: FILKRI completes Accord BioPharma’s comprehensive granulocyte colony-stimulating factor (G-CSF) portfolio alongside UDENYCA® (pegfilgrastim-cbqv) RALEIGH, N.C., Feb.…

    Read More »
  • Oakland County diverts mental health patients to ERs amid crisis center takeover

    Law enforcement is Oakland County is being asked to divert individuals in severe psychological crisis to hospitals rather than a designated facility in Pontiac  Critics say the practice burdens both emergency departments and police officers, who lack specialized training and resources The Michigan Mental Health Association says the action is having a “chilling effect” on network providers TROY – Mental…

    Read More »
Back to top button
close